双环醇对人肝癌细胞HepG2的周期抑制及自噬诱导作用的研究
[Abstract]:Hepatocellular carcinoma is the fifth largest tumor in the world and has a very high morbidity and mortality. Although a variety of methods such as chemotherapy, excision, liver transplantation, and immunotherapy have been used to treat the liver cancer, the survival rate of the liver cancer is only 3-5% in the developed countries, which has prompted the people to continue to find new methods of treating the liver cancer. Bicyclol (4,4 '-dimethoxy-5,6,5',6 '-bis (methylenedioxy) -2-hydroxymethyl-2'-methoxyphenyl) is a new drug for anti-hepatitis chemical synthesis, and has been widely used in the treatment of HBV infection. In addition, some studies have shown that the bicyclol also has the function of improving the liver function, It is also found that the double-ring alcohol can induce the expression of the heat shock protein HSP27/70 in the liver cancer cell, thereby inhibiting the apoptosis of the mitochondrial pathway of the cell. The anti-tumor effect of the double-ring alcohol and the study of the function of the double-ring alcohol in the cell cycle and autophagy of the tumor are still rare, The preliminary study on the high-throughput screening of differentially expressed genes in the cancer cells after the double-ring alcohol in the relevant literature shows that the double-ring alcohol has the potential as an anti-cancer drug, and therefore, the research focuses on the toxic effect of the bicyclol on the HepG2 cells, And the molecular mechanism of the double-ring alcohol on the action of the liver cancer cells is explored in the in vitro and in vivo environment, and the results are as follows:1. the double-ring alcohol can obviously inhibit the proliferation of the HepG2 cells, and the toxicity to the normal liver cells LO2 is very low. The IC50 value of bicyclol on HepG2 cells is one-third of the LO2 cell, and by flow cytometry it is found that the inhibitory effect of bicyclol on the activity of HepG2 cells is mainly due to its ability to inhibit cell cycle and to induce autophagy of the cells, and the level of apoptosis of HepG2 cells under the action of the bicyclol is not changed. In the aspect of the cell cycle, the double-ring alcohol can induce the G1 phase cell block which is dependent on the time and the concentration gradient of the HepG2 cells, In addition, the observation of GFP-RFP-LC3 transfected cells and the direct observation of transmission electron microscope (TEM) of GFP-RFP-LC3 were observed by fluorescence microscope. The number of autophagy bodies and autophagy lysosomes in the cells increased significantly after the double-ring alcohol induction treatment. These results indicated that the double-ring alcohol inhibited the cell activity of HepG2 by inhibiting the cell cycle and the autophagy of the cells.2. The bicyclol inhibited the PI3K/ AKT pathway and the Ras/ Raf/ MEK/ ERK pathway at the same time. The double-ring alcohol can induce the expression of p21CIP1 and p27KIP1, inhibit the level of CDK2-cyclinE and CDK4-cyclinD complex, and dephosphorylation of Rb protein results in cell cycle arrest in G1 phase. At the same time, it was found that the double-ring alcohol induced autophagy of the cell by inhibiting the activity of mTOR protein. By further studying the upstream signal path of the cycle and autophagy, it was found that the double-ring alcohol significantly inhibited the phosphorylation of the AKT protein. The PI3K/ AKT pathway was downregulated. The effect of Bicyclol on the cycle inhibition and autophagy of the tumor cells was reduced by the transfection of AKTcDNA. The results show that AKT plays an important role in the inhibition of tumor cell activity. The results indicated that the cytotoxicity of the double-ring alcohol was closely related to the PI3K/ AKT pathway and the Ras/ Raf/ MEK/ ERK pathway. The effect of the alcohol in the in vivo environment is that the HepG2 cells are transplanted to a nude mouse by an underarm transplantation method, and the bicyclol and sorafenib are administered by oral administration. The results show that the bicyclol reduces the tumor volume in the mice and reduces the weight of the tumor, The method of HE staining and TUNEL staining showed that the double-ring alcohol in the tumor tissue caused a certain degree of death of the tumor cells, and no similar phenomenon was found in the liver tissue. Western blotting and immunohistochemistry were performed on the tumor tissues. In conclusion, the inhibition and proliferation of the bicyclol on the tumor cells is derived from cell cycle inhibition and autophagy. In vitro and in vivo environment, The toxicity of the double-ring alcohol is related to the inhibition of the PI3K/ AKT pathway and the Ras/ Raf/ MEK/ ERK pathway.
【学位授予单位】:浙江大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R735.7
【相似文献】
相关期刊论文 前10条
1 李燕;;双环醇片的药理研究和临床应用[J];传染病信息;2002年02期
2 王铁华,石庆平;反相高效液相色谱法测定血清中双环醇的含量[J];医药导报;2003年10期
3 谌玲如,孙玲华,肖菊兰;双环醇治疗慢性病毒性乙型肝炎疗效观察[J];江西医药;2004年02期
4 宋伟峰;林潮双;李瑞珍;;双环醇治疗慢性乙型病毒性肝炎50例疗效观察[J];广东药学;2005年05期
5 徐芸;文小岗;王振豫;李继昌;;双环醇片治疗非酒精性脂肪性肝病疗效分析[J];肝脏;2006年05期
6 廖柏明;;双环醇治疗非酒精性脂肪性肝病疗效观察[J];首都医药;2011年06期
7 翁吉敏;国家一类抗肝炎新药双环醇片[J];中华医学杂志;2002年09期
8 ;国家一类抗肝炎新药双环醇片[J];中华医学杂志;2002年11期
9 ;国家一类抗肝炎新药双环醇片[J];中华医学杂志;2002年12期
10 郭强,张玉江,王靖,苏翠丽,常霞;双环醇治疗慢性丙型病毒性肝炎的临床应用评价[J];中国医院用药评价与分析;2003年06期
相关会议论文 前10条
1 刘玉玲;李燕;陈丙跃;王春霞;夏学军;王洪亮;金笃嘉;鲁小笋;汪仁芸;陈晖;;难溶性抗肝炎新药双环醇促吸收技术及控释制剂研究[A];科技、工程与经济社会协调发展——中国科协第五届青年学术年会论文集[C];2004年
2 王志明;陈伟华;刘丽宁;李明山;田琦琦;;双环醇治疗慢性乙型肝炎患者52例疗效观察[A];中华医学会第十二次全国病毒性肝炎及肝病学术会议论文汇编[C];2005年
3 刘耕陶;;双环醇药理研究的新进展及抗肝炎药研究的展望[A];2006年慢性乙型肝炎治疗进展研讨会资料汇编[C];2006年
4 沈玲;赵伟;方之勋;李定坤;杨毅军;詹熔娥;钟备;徐乾;文睿;舒伟平;;双环醇治疗慢性乙型肝炎临床研究[A];第五届全国肝脏疾病临床暨中华肝脏病杂志成立十周年学术会议论文汇编[C];2006年
5 谷雨;李燕;;双环醇对免疫性肝纤维化大鼠的保护作用及机制研究[A];全国第十一届生化与分子药理学学术会议论文集[C];2009年
6 薛猛;崔洁;钱令波;夏强;;双环醇对抗在体大鼠心肌缺血-再灌损伤的保护作用[A];浙江省生理科学会2008年学术年会论文汇编[C];2008年
7 姚晓敏;李燕;;双环醇对大鼠肝脏缺血再灌注损伤的保护作用[A];第十届全国生化与分子药理学术会议论文摘要汇编[C];2007年
8 于红燕;李燕;;双环醇对四环素引起小鼠脂肪肝的保护作用及机制研究[A];全国第十一届生化与分子药理学学术会议论文集[C];2009年
9 林国贤;黄庆华;林玉英;吴智宏;邱荣仙;何雄志;叶向阳;胡震霆;;双环醇治疗妊娠合并肝功能异常患者的疗效和安全性分析[A];中华医学会第十六次全国病毒性肝炎及肝病学术会议论文汇编[C];2013年
10 苏光扬;;双环醇与苦参素治疗慢性乙型肝炎临床疗效对比[A];2006年浙江省感染病、肝病学术会议论文汇编[C];2006年
相关重要报纸文章 前6条
1 李和平;抗肝炎药双环醇研究获国家科技进步奖[N];中国医药报;2007年
2 李和平;双环醇研究获2005年北京市科技一等奖[N];中国医药报;2006年
3 王海;抗肝炎新药双环醇研究获奖[N];医药经济报;2007年
4 付德明;双环醇可治慢性乙肝[N];中国医药报;2004年
5 王振坤;治疗肝病良药——双环醇[N];家庭医生报;2006年
6 江沪沪;我国人工合成抗肝炎新药“双环醇”[N];光明日报;2000年
相关博士学位论文 前10条
1 王_g;双环醇对人肝癌细胞HepG2的周期抑制及自噬诱导作用的研究[D];浙江大学;2016年
2 赵冬梅;抗肝炎新药双环醇的肝脏药理学作用机理研究[D];中国协和医科大学;2002年
3 于红燕;双环醇对实验性非酒精性脂肪肝的保护作用及机制研究[D];中国协和医科大学;2010年
4 李敏;双环醇抗肝细胞损伤的免疫学机制[D];中国协和医科大学;2004年
5 王慧萍;双环醇对小鼠急性肝衰竭的保护作用及机制研究[D];中国协和医科大学;2006年
6 胡庆伟;双环醇抗肝纤维化及其作用机制的研究[D];中国协和医科大学;2006年
7 刘鑫;双环醇对药物性肝损伤的保护作用及机制研究[D];北京协和医学院;2015年
8 李烨;双环醇对实验性肝损伤、肝纤维化的保护作用和作用机制的研究[D];中国协和医科大学;2001年
9 赵菁;双环醇对小鼠急性酒精性肝损伤和肝细胞凋亡的保护作用及机制研究[D];中国协和医科大学;2009年
10 娄小娥;双环醇对CpG-ODN诱导的肝损伤的保护作用及机制研究[D];浙江大学;2009年
相关硕士学位论文 前10条
1 林栖;双环醇对小鼠急性放射损伤保护作用的实验研究[D];福建医科大学;2015年
2 张友文;双环醇对次黄嘌呤脱氢酶Ⅱ的作用及其抗炎机制研究[D];北京协和医学院;2015年
3 张鑫;双环醇脂质体的制备及体内药代动力学的研究[D];河南大学;2015年
4 周亮亮;双环醇对肝星状细胞增殖及凋亡的影响[D];河北医科大学;2009年
5 茹筱晨;双环醇对超氧阴离子诱导的血管内皮功能损伤的影响及其机制[D];浙江大学;2010年
6 祁文s,
本文编号:2476390
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2476390.html